lf.A personal publicationItaliano
Beyondliminalfinds.com

Time Moving a Hundred Times Slower

Two patients with anti-NMDA receptor encephalitis felt hours stretch by multiples before antibodies were found. Their doctors propose slow-motion time as an early clinical clue, though two selected cases cannot yet establish how often it appears.

Graphite pencil drawing on pale paper of a small glass pitcher tilted over a drinking glass, with a single thin thread of water and one droplet hanging motionless mid-air above a still surface.
AI-generated editorial illustration.

Three days before entering Osaka Red Cross Hospital, a 40-year-old office worker began seeing the world in sepia tones and feeling that time had slipped out of pace. Six weeks earlier he had had a brief headache and a 38 °C fever that faded on its own. By the night before his emergency visit, time felt ten times slower; by the next morning, a hundred times slower. He could barely sleep an hour a night and arrived with thoughts of suicide.

Over the following days in the psychiatric ward, his symptoms looked at first like an acute psychotic breakdown. On day four he banged on the door of his room, repeating, "there is someone else in me." On day ten he thought he was in a bank, said he was 1,020 years old, and heard the nurses speaking in slow motion. Only spinal fluid testing confirmed what was happening: antibodies against the GluN1 subunit of the NMDA receptor were attacking his own synapses.

The case appeared in BMC Neurology in February 2025, written by Risa Hirata, Michitaka Funayama, and five colleagues in the neuropsychiatry departments of the Osaka and Ashikaga Red Cross hospitals. Alongside the 40-year-old man, they describe a 28-year-old woman whose illness began with strange sounds in her ears at a flower-viewing festival, followed by panic over the taste of food, aimless pacing, crawling in circles, and catatonia. Only after steroid pulse therapy lifted her confusion on hospital day ten did she say what had happened before admission: "Before I was hospitalized in the psychiatric facility, my sense of time felt about 2 or 3 times slower, but now it’s back to normal."

Why the first clue arrives in a psychiatric ward

Anti-NMDA receptor encephalitis is an autoimmune inflammation of the brain, first defined in the late 2000s. Early immunotherapy leads to substantial recovery in 70% to 80% of patients, according to the clinical series cited by Hirata and her co-authors, while 29% require intensive care and 5% to 11% die. The bottleneck is recognizing it early. In its opening phase, 59% of patients present with psychiatric symptoms rather than obvious neurological signs; up to 77% see a psychiatrist first, and 31% are initially admitted to psychiatric wards.

Routine tests often stall at the exact moment a decision is needed. According to the diagnostic studies cited in the report, brain MRI shows no abnormalities in up to 70% of patients, and confirming anti-NMDA receptor antibodies in cerebrospinal fluid takes time. In the 28-year-old woman’s case, both her brain MRI and an abdominal MRI looking for an ovarian teratoma—a tumour often associated with the condition—were normal, and an 80 mg antipsychotic patch produced no improvement. What finally pointed away from a primary psychiatric disorder was a combination of subtle signs: no prior mental health history, involuntary upper-limb movements, a characteristic slow-wave pattern on her EEG called extreme delta brush, and a mildly elevated white-cell count in her spinal fluid.

The man’s case lingered much longer in perception than in acute confusion. After four cycles of high-dose steroids, intravenous immunoglobulin, and cyclophosphamide, his orientation returned around day 35 and he went home on day 74 with a Mini-Mental State score of 29. Nine months later he was back at his clerical job. Yet ten months after discharge, he still reported that time slowed to half its usual pace whenever he felt stressed.

The receptor that stretches an instant

There is a straightforward pharmacological reason to suspect NMDA receptors when someone complains that seconds are dragging. Drugs that block the same receptor—ketamine and phencyclidine—produce marked time distortion in healthy people. In a 2006 phenomenological study by Edith Pomarol-Clotet and colleagues, 15 healthy volunteers received intravenous ketamine under controlled conditions; 11 of them reported an altered sense of time, most often slowing down. "It’s stopped, feels like I’ve been here for hours," one volunteer said, alongside sensations of motor inertia—"noticeable delay between thinking about moving and it happening"—without true hallucinations.

Because autoantibodies in anti-NMDA receptor encephalitis reduce and internalize those same receptors, Hirata and her colleagues expected a parallel distortion. Yet in the published literature they could find only one prior report mentioning time distortion explicitly in this condition: a 2018 Neurocase paper co-authored by Funayama himself, which described two earlier patients whose altered time sense stood out during acute psychosis.

What two cases can and cannot separate

To test whether slow-motion time could help clinicians tell autoimmune encephalitis apart from schizophrenia in an outpatient clinic before an MRI or lumbar puncture is done, the authors compare their patients with two external baselines. First, they cite a 2016 Schizophrenia Bulletin study by Giovanni Stanghellini and colleagues on 301 patients with schizophrenia: 109 reported abnormal time experience, usually a fragmented sense of time—seeing the world "like a series of photographs"—while only 12 (4.0%) described time moving slowly. Second, they cite reviews of Alice in Wonderland syndrome by Jan Dirk Blom (2016) and Giulio Mastria and colleagues (2016), where viral encephalitis such as Epstein-Barr or influenza rarely produces isolated time distortion without prominent visual warping of size and shape.

Here the evidence narrows sharply. Hirata and her co-authors pool their two Osaka patients with the two cases from Funayama’s 2018 Neurocase paper and note that three of those four patients (75%) experienced slow-motion time. That percentage is not a prevalence rate. Between June 2023 and June 2024, the Osaka team explicitly selected these two cases for publication because both experienced time distortion, and a senior psychiatrist questioned them specifically about time perception at least once a week during admission and monthly afterward. Comparing a denominator built by case selection against a consecutive 15-year cohort of schizophrenia patients mixes two different kinds of measurement.

The multipliers themselves also rest entirely on subjective recollection rather than stopwatch tasks. In the 40-year-old man’s clinical summary, his time distortion is described as "up to 100-fold" on the day of admission, then later, in the paragraph describing his improvement around day 35, as having dropped "from a severe 1000-fold distortion to a 2-fold distortion." The report never clarifies whether the distortion worsened tenfold more in the hospital or whether one of the figures is an approximate slip, nor could either patient explain how they arrived at 2×, 3×, 10×, or 100×. The young woman did not mention time at all while catatonic; she could only estimate "2 or 3 times slower" retrospectively once her confusion cleared.

The authors openly acknowledge the main gaps: their sample is tiny, restricted to psychiatric admissions, and leaves unknown how often slow-motion time occurs across unselected patients with anti-NMDA receptor encephalitis—or in patients who carry NMDA receptor antibodies alongside a schizophrenia-spectrum diagnosis. Asking a patient whether time feels unusually slow costs nothing and takes only a moment during an intake interview. Until larger, unselected cohorts are followed from admission, it remains a useful question to ask rather than a sign that can diagnose the illness on its own.

02 / A Note on Sources

A Note on Sources

I read the complete open-access text of Hirata et al., "Time moving 100-fold slower: time distortion as a diagnostic clue in anti-NMDA receptor encephalitis," BMC Neurology 25:75 (24 February 2025, PMC11849365), from which all clinical timelines, medication doses, CSF counts, MRI/EEG findings, the 100-fold/1000-fold wording in Case 1, and Case 2’s retrospective quote are taken. I also read in full Pomarol-Clotet et al. (2006, PMC3838932) on intravenous ketamine in 15 healthy volunteers and Blom (2016, PMC4909520) on Alice in Wonderland syndrome. For Funayama et al. (Neurocase 2018, PMID 30681026) and Funayama et al. (J Psychiatr Res 2022, PMID 35597225), I read the PubMed abstracts; for Stanghellini et al. (Schizophrenia Bulletin 2016, PMC4681541), only the abstract was available in the PMC XML feed, so the specific count of 12/301 (4.0%) slow-motion reports is cited as reported by Hirata et al. Background epidemiology (59% initial psychiatric presentation, 70% normal MRI, 70–80% recovery) comes from the prior studies summarized in Hirata et al., whose primary papers were not consulted individually.

03 / Sources

Time distortion in anti-NMDA receptor encephalitis

Two Osaka Red Cross Hospital case reports (2025), experimental ketamine time-slowing data (2006), and comparative studies on schizophrenia and Alice in Wonderland syndrome.

The case report

NMDA antagonism and earlier cases

Differential comparisons

How this was written: researched and drafted with the help of AI tools, starting from the sources listed here. Editorial responsibility for what is published is mine. Corrections: hello@liminalfinds.com.

If this was worth your time, you can support Liminal Finds (opens in a new tab).